German METHOD The present study was a monocentric retrospective analysis of prospectively collected data among children and adolescents with CP participating in a rehabilitation programme. Excess body fat was defined as a body fat percentage above the 85th centile assessed by dual-energy X-ray absorptiometry.
The World Health Organization (WHO) defines overweight and obesity as abnormal or excessive fat accumulation that may impair health. 1 Overweight and obesity among children and adolescents are associated with higher risk of adult obesity and are major risk factors for diseases such as hypertension, early markers of cardiovascular disease, and insulin resistance. 2 Body mass index (BMI), defined as a person's weight in kg divided by the square of the person's height in meters (kg/m 2 ), is commonly used to identify overweight and obesity in adults. To define overweight and obesity in children, age-related reference centiles are used. 1 Although the BMI is easy to apply and epidemiological data showed an association between increased BMI and cardiovascular events, 2 the BMI is not able to distinguish between fat mass and lean body mass. 3 Thus, BMI tends to overestimate body fat in individuals who are muscular and underestimates body fat in individuals with low lean body mass.
The prevalence of overweight or obesity (using BMI) among children and adolescents in the USA was 31.8% in 2011 to 2012. 4 Studies indicated that the prevalence of overweight in children with physical impairment and intellectual disability may be higher than in typically developing children. 5 A recent systematic review has shown that BMI had high specificity but low sensitivity to detect obesity and fails to identify more than 25% of otherwise typically developing children with excess body fat percentage. 6 Kuperminc et al. showed that BMI is a poor predictor to detect excess body fat in children with moderate-to-severe cerebral palsy (CP). 7 CP is a group of disorders caused by permanent but not progressive damage of the developing brain, and is the most common cause of physical impairment in children (with an incidence of about two per 1000 live births).
Tools directly assessing fat mass, such as dual-energy X-ray absorptiometry (DXA) or hydrostatic weighing, are validated methods for measurement of obesity. However, these methods are more invasive than BMI and their use is limited by cost, availability, and the lack of widely accepted cut-off values of normal body fat percentage in children.
Therefore, BMI is widely recommended by institutions such as WHO, the World Obesity Federation (WOF), and the German Society for Adiposity (DAG) for screening children. 1, 8, 9 Interestingly, all three institutions use different reference centiles and BMI cut-off values to identify overweight and obesity in children.
The aims of the study were: (1) to evaluate and compare the prevalence of overweight and obesity assessed by BMI and excess body fat assessed using DXA in children with CP; (2) to calculate the diagnostic performance of BMI cut-off values for overweight according to the recommendations of WHO, WOF, and DAG to identify excess body fat in children with CP; and (3) if possible, to adjust existing cut-off values to improve the diagnostic performance of BMI in children with CP.
METHOD Study design and terminology
The present study was a monocentric retrospective analysis of prospectively collected data. The participants were children and adolescents with CP, who participated in the rehabilitation programme 'On your feet' at the Center of Prevention and Rehabilitation (University of Cologne, Cologne, Germany) from January 2006 to January 2015. The rehabilitation programme has been previously described.
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A whole-body DXA per patient was carried out at the beginning of the rehabilitation in children older than 5 years of age. We performed 877 whole-body DXAs within 9 years. Next to an acquired or congenital CP, the inclusion criteria were white ethnicity (to conform with the reference centiles of body fat percentage assessed by DXA), as well as an age range of 8 to 20 years. Patients with additional diagnosed genetic syndromes were excluded from the study. In total, DXAs from 329 individuals were included in the statistical analyses (Table I ). The main reasons for exclusion were: (1) no CP or diagnosis of additional genetic syndromes (n=92); (2) repeated measures in the same child (n=286, only the first measure was included); and (3) subjects not fulfilling the age criterion (n=170).
After obtaining written informed consent from the legal guardian of the child, the participants' data were stored in a prospective monocentric patient registry. The ethics committee of the University of Cologne approved this registry . A detailed description of the registry can be found at http://www.germanctr.de (DRKS00011331), which is a primary register of the International Clinical Trials Registry Platform of the WHO.
In the following, excess body fat referred to an increased body fat percentage, which was determined by DXA. In the literature the recommended cut-off values for excess body fat by DXA varied between the 85th and 95th centiles. 6 However, Lamb et al. showed that US adolescents with a body fat percentage above the 75th centile had significantly more adverse lipid concentrations than those with a body fat percentage below the 75th centile. 11 In the present study, excess body fat was defined as a body fat percentage at or above the 85th centile as described by Freedman et al. (Table II) . 12 The used reference centiles for body fat percentage were device and software specific and were published by Fan et al. for Caucasian children from 8 to 20 years. 13 Further, we defined overweight and obesity as increased body fat content, assessed by BMI. As mentioned, we used the BMI cut-off values according to the recommendations of the WHO, WOF, and DAG (Table II) . Cut-off values for overweight per WHO, WOF, and DAG recommendations were then used as a test of excess body fat, with the DXA-based criterion standard used as the true value of the presence or absence of excess body fat. c Children in GMFCS levels III-V were significantly shorter (p<0.001) and lighter (p=0.006) than children in GMFCS level I or II. d z-scores were calculated according reference of Fan et al. 13 e Male children had significantly lower LBM z-scores than female children (p=0.010). BMI, body mass index; LBM, lean body mass.
What this paper adds
• Excess body fat in children with cerebral palsy (CP) is less common than previously reported.
• Body mass index (BMI) had high specificity but low sensitivity in detecting excess body fat in children with CP.
• BMI evaluation criteria of the German Society for Adiposity could be improved in children with CP.
To evaluate the effect of level of disability on the prevalence of excess body fat, the study population was divided into two subgroups (Gross Motor Function Classification System [GMFCS] level III and GMFCS levels III-V). This classification of ambulatory (GMFCS level I or II) versus ambulatory with aids (GMFCS level III) or non-ambulatory (GMFCS levels IV and V) is common in the literature.
The CP subtypes were classified as spastic bilateral, spastic unilateral, dyskinetic, ataxic, and mixed type, in accordance with the criteria of the Surveillance of Cerebral Palsy in Europe.
A demographic and clinical overview of the study population is given in Table I .
DXA measurement and data acquisition
DXA was performed using Prodigy Advance (January 2006-March 2011; GE Healthcare, Little Chalfont, UK) and iDXA (April 2011-January 2015; GE Healthcare, Little Chalfont, UK) with the Encore software in its versions 10 to 14 (GE Healthcare, Little Chalfont, UK). Body fat percentage was determined by the whole-body measurement and was recalculated with the Encore software version 14.1 on iDXA. Quality-control assurance measurements were performed according to the manufacturer's recommendations.
Positioning on the device and clothing was executed according to the manufacturer's instructions. The measurements were carried out by two trained and long-time experienced examiners (B. Tutlewski, B. Sommer). Only valid measurements were eligible for the analysis. The mean absolute difference between body weights measured by DXA and by a digital scale was 1.26% (standard deviation [SD] 1.45; Pearson's correlation coefficient=0.999). Body length was assessed with a stadiometer SECA No. 213 (SECA, Hamburg, Germany) in children who were able to stand, and in children who were unable to stand, an extendable metal tape was used (Kingsize M, Weiss Messwerkzeuge, Erbendorf, Germany). In children with joint contractures in the lower limb, the length was measured in supine position with passive correction of the contractures as far as possible.
Diagnostic performance of BMI cut-off values and its optimization
We evaluated the diagnostic test performance of the mentioned BMI cut-off values for overweight with regard to the recognition of excess body fat in children with CP. BMI values higher than the cut-off value predicted the presence of excess body fat. Thus, the BMI value served as a binary classifier, as did the cut-off value of 85% DXA-determined body fat percentage. Then, using the DXA-determined presence of excess body fat as the criterion standard for true presence of excess body fat, and the BMI-predicted presence of excess body fat as the test, we calculated the: (1) sensitivity and specificity; (2) positive and negative predictive value; (3) test accuracy (corresponds to number of correct assessments/number of all assessments); (4) likelihood ratio for a positive and negative test; (5) diagnostic odds ratio (corresponds to positive likelihood ratio/negative likelihood ratio); and (5) the Youden's index (corresponds to sensitivity + specificity -1).
A variety of methods, such as the Youden's index, have been described in the literature to optimize cut-off values. In order to achieve a comparability with the results of the meta-analysis of the diagnostic performance of the BMI value in children without CP, a method proposed by Sch€ afer was used.
14 The method defines a minimum value for specificity, while maximizing the sensitivity. In the present study, the minimum value for specificity was the pooled value for specificity in children without CP according to the meta-analysis of Javed et al. (93%). 6 These calculations were performed with the R package 'OptimalCutpoints', versions 1.1-3. 15 
Statistical analysis
Age-adjusted z-scores for height were calculated using the latest growth charts for Germany. 16 The distributions of the data were explored through Q-Q plots, Shapiro-Wilk test, and Kolmogorov-Smirnov test. For variables with a normal distribution, t-test statistics were used to compare means of subgroup, and Mann-Whitney U tests were used for variables with a non-normal distribution. For comparison of variables with binary distribution, the v 2 or exact Fisher test were used.
If not stated otherwise, results are given as mean (1SD). Descriptive and statistical analyses were performed using SPSS Statistics for Windows, Version 23.0 (IBM, Armonk, NY, USA) and R Version 3.2.5 (R Foundation for Statistical Computing, Vienna, Austria). Diagnostic performance of BMI as a binary classifier was analysed by R package epiR, version 0.9-79 (R Foundation for Statistical Computing). 
RESULTS

Study population
In total, 329 children with CP (181 males, 148 females) were eligible for analysis (Table I) . Of these, 105 were classified as in GMFCS level I or II (Table I) . Most of the participants had bilateral spastic CP (85.4%, n=281). Mean age was 12 years 4 months (SD 2y 9mo). The mean height-for-age z-score was À1.55 (SD 1.28). Children in GMFCS level III to V were significantly (p<0.001) shorter and lighter (p=0.006) than children in GMFCS level I or II (mean height z-score À 0.92 vs À1.84). Contractures that might have an impact on length were not recorded in this study. The mean BMI z-score was À0.60 (SD 1.56) without significant difference between the children in GMFCS level I or II, and levels III to V. The mean lean body mass (assessed by whole-body DXA) z-score was À0.33 (SD 1.55). Males with CP had a significantly (p=0.010) smaller mean lean body mass z-score than females (mean lean body mass z-score À 0.46 vs À0.17).
The distributions of CP subtypes were comparable between males versus females, participants 12-years-old and younger versus participants older than 12 years, and participants in GMFCS level I or II versus participants in GMFCS levels III to V.
Prevalence of excess body fat, overweight, and obesity
The densitometrically assessed prevalence of excess body fat in our study was 17.0% (95% confidence interval [CI] 13.21-21.62; Table III ). The prevalence of excess body fat was significantly higher (p=0.045) in children in GMFCS levels III to V than in those in GMFCS level I or II.
The prevalence of overweight and obesity according to WHO, WOF, and DAG BMI cut-off values are given in Table III .
Diagnostic performance of BMI cut-offs and their optimization
According to the BMI cut-offs of the WHO, BMI had a sensitivity of 0.768 (95% CI 0.636-0.870) and a specificity of 0.894 (95% CI 0.851-0.928; Table IV) to predict excess body fat in our study population. The BMI had sensitivity of 0.696 (95% CI 0.559-0.812) and a specificity of 0.934 (95% CI 0.898-0.960; Table IV), according to the BMI cut-offs of the WOF.
Furthermore, when using the BMI cut-offs of the DAG, BMI showed a predictive sensitivity of 0.411 (95% CI 0.281-0.550) and a specificity of 0.993 (95% CI 0.974-0.999; Table IV ). The detailed test performance criteria, classified according to the respective recommendations are depicted in Table IV .
The diagnostic test performances of the three BMI evaluation criteria (WHO, WOF, DAG), after carrying out the optimization procedure, are given in Table IV 
DISCUSSION
The prevalence of excess body fat in children with CP in our study group is 17.0% (95% CI 13.2-21.6; Table III) .
In three comparable studies, a relevantly higher prevalence of 46.9% to 63.8% of excess body fat has been reported. In these studies, excess body fat assessed by DXA was defined according to Lohman as a body fat percentage of 25% for males and 30% for females. 7, [17] [18] [19] The study populations (47, 58, and 128 children with mild-to-severe CP) were smaller than ours. The prevalence of excess body fat in our study population assessed with the BMI cut-off values of Lohman is 47.7%, which is similar to the data given by Oeffinger et al. (60/128 children; 46.9%). 18 As the body composition in children changes with the age, 13 we suppose that a fixed percentage for a cut-off value of body fat percentage is inaccurate. Furthermore, measurements of a DXA should only be assessed with device and softwarespecific reference values. Thus, it seems that the prevalence of excess body fat in children with CP was overestimated by previous studies. This assumption is also supported by the fact that 3470 of 6754 typically developing children (51.4%) from the National Health and Nutrition Survey (USA) 1999 to 2004 had excess body fat with the cut-off values of Lohman. 7, 17 In addition, Walker et al. found no significant difference in body fat percentage when comparing preschool-aged children with CP with typically developing children. 20 In accordance with the existing literature, the level of disability seems to be a risk factor for excess body fat in children with CP (Table III) . [19] [20] [21] In the literature, the following possible reasons for this were stated: (1) children with physical disability have more difficulties finding suitable sports groups or gyms; (2) children with physical disability showed reduced outdoor activities, as they are increasingly prone to accidents due to a non-disabilityfriendly environment; (3) reduced muscle mass could lead to an increase of body fat percentage, as both are components of total body weight; (4) the financial expense of special equipment is often a hindrance to regular physical activity. 22, 23 In addition, in our study population, there was a trend towards higher prevalence of excess body fat in males with CP, as well as in patients older than 12 years of age (Table III) .
One explanation for the sex difference could be the significantly lower height-adjusted z-scores for lean body mass in males with CP than in females with CP (À0.46 vs À0.17; Table I ). The smaller the lean body mass, the higher the body fat percentage will be for the same fat mass. It should be mentioned that, as in typically developing children, 24 the absolute mean body fat percentage in our study population was lower in males than in females (27.35 AE 9.47% vs 31.94 AE 7.88%). However, our Table II definition of excess body fat was based on the z-score of body fat percentage and not on the absolute value. The prevalence of overweight, including obesity, in children with CP in our study group depended on the BMI evaluation criteria used (WHO, WOF, or DAG), and was between 7.6% and 21.9% (Table IV) . In Germany, the prevalence of overweight, including obesity, was reported to be 14.9% in children aged 4 to 10 years and 18.9% in children aged 11 to 17 years. 25, 26 According to the WHO and WOF BMI evaluation criteria, the prevalence of overweight, including obesity, in our study population is comparable. On the contrary, according to the BMI evaluation criteria of DAG, the prevalence seems to be underestimated (7.5%).
No data for the prevalence of overweight, including obesity, in children with CP was found in Germany. In children with physical or intellectual disabilities from the Netherlands (n=85), the prevalence of overweight, including obesity, was reported to be 30.6%. 27 Hurvitz et al. reported a prevalence of overweight, including obesity, of 29.2% in children with CP (GMFCS levels I-V, n=137).
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The reason why the prevalence of overweight, including obesity, in our study population is lower may be owing to the high proportion of children in GMFCS levels I to III (mild-to-moderate motor impairment, n=238 [72.3%]). Indeed, Pascoe et al. reported that the prevalence of overweight, including obesity, in their comparable study group of children with CP and in GMFCS levels I to III was 19.2%. 21 It is noteworthy that the prevalence of densitometrically determined excess body fat and the prevalence of overweight, including obesity, determined by BMI in our study population are very similar. On the contrary, while using the WHO and WOF BMI cut-offs for overweight, about 25% of the children with excess body fat in our population are not recognized as such (sensitivity for WHO and WOF BMI cut-offs are 0.77 and 0.70 respectively). The specificity of the WHO criteria is 0.894 and the specificity of the WOF criteria is 0.934 (Table IV) . The values for pooled sensitivity and specificity of BMI in typically developing children determined within a recently published large-scale meta-analysis were comparable (sensitivity 0.73, specificity 0.93). 6 Finbr aten et al. reported a similar sensitivity and specificity in children with CP. 19 In contrast, Kuperminc et al. reported that BMI had a much lower sensitivity in children with CP, 7 possibly attributed to the use of the above-mentioned fixed body fat percentage cutoff values. The BMI cut-off values for overweight proposed by the WHO and the WOF could not be optimized relevantly to predict excess body fat in our study population (Table IV) .
However, when applying the DAG BMI cut-off for overweight, only 41.1% of the children with excess body fat are recognized as such in our study population. The specificity is 0.993 (Table IV) . The sensitivity of BMI cut-offs proposed by DAG have been improved by reducing the cut-off values. Therefore, the diagnostic performance of the DAG criteria is comparable with those of WHO and WOF (Table IV) . In addition to the 90th centile, the BMI reference intervals commonly used in Germany depict the 75th centile but not the 85th. For reasons of practicality, even though the 85th centile seems to be the best cut-off value for the prediction of excess body fat in females with CP, we recommend using the 75th centile for both sexes.
The 97th centile of the DAG BMI reference is higher than the 97th centiles of the WHO and WOF BMI reference. This was most likely the reason for the lower sensitivity of the DAG-based BMI cut-off in predicting excess body fat, assessed by DXA, than the sensitivity of WHO and WOF-based BMI cut-offs. In addition, this explains the different results of the optimization procedures (Fig. S1, online supporting information) .
In summary, BMI showed high specificity but low sensitivity in children with CP. This diagnostic performance of BMI is also known in typically developing children. To predict excess body fat in our study population, the BMI cut-off value for overweight proposed by DAG, but not the BMI cut-off values proposed by the WHO and the WOF, could be optimized. Monitoring excess body fat only using BMI may lead to a failure to notice 'normal-weight obese' children. In adults‚ 'normal-weight obesity' seems to be associated with a high prevalence of cardiovascular risk factors. 29 The metabolic effects of 'normal-weight obesity' in children is not yet known. Measuring skinfold thickness or abdominal circumference are possible useful alternatives to improve the detection of excess body fat in children with CP and should be further assessed. Further research is needed, to determine the most reliable tools to recognize children with 'normal-weight obesity'.
Limitations
This study was based on a retrospective analysis of data collected as part of a standard clinical care during a rehabilitation programme. Therefore, the study population might not be a representative sample of all children with CP ('selection bias'). Further, lower-limb contractures, a common finding in children with CP, could have complicated the height measurement and thus the BMI calculation in the study.
